exa-cel
Vertex pharmaceuticals,CRISPR therapeutics AG
[]
vertex and crispr therapeutics present new data on more patients with longer follow-up treated with exagamglogene autotemcel (exa-cel) at the 2022 european hematology association (eha) congress - 
MD MSC CPDS https://t.co/kePCRsvthW  https://t.co/t7oxnCDRg8  #cardiology  #AI #informatics #healthcare #innovation #entrepreneur RSS feeds